RKDA Earnings

Quarterly EPS
$-1.18
Q3 2024
$-0.98
Q4 2024
$1.90
Q1 2025
$-3.26
Q2 2025
$0.63
Q3 2025
$-0.97
Q4 2025
$-2.11
Q1 2026
$-2.09
Q2 2026
Latest Revenue1.4M
Latest Net Income-6266000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.091.4M-6266000-0.8%+35.9%
Q1 2026-$2.111.1M-4385000-8.3%-211.1%
Q4 2025-$0.97901.0K-1336000-25.9%+1.0%
Q3 2025$0.631.3M856.0K-15.3%+153.4%
Q2 2025-$3.261.5M-4458000+11.4%-517.9%
Q1 2025$1.901.2M2.6M+21.6%+206.7%
Q4 2024-$0.981.2M-1343000+56.5%+53.1%
Q3 2024-$1.181.5M-1612000+18.4%+37.6%
Q2 2024$0.781.3M1.1M
Q1 2024-$1.78987.0K-2423000
Q4 2023-$2.09777.0K-2853000
Q3 2023-$1.891.3M-2567000
Arcadia Biosciences (RKDA) — Earnings